Cookson Peirce & CO Inc Moderna, Inc. Transaction History

Cookson Peirce & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	BUY	$118.38 - $210.04 $586,691 - $1.04 Million	4,956 New	4,956 $890,000
Q4 2021 Jan 31, 2022	SELL	$225.82 - $368.51 $1.13 Million - $1.84 Million	-4,982 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$221.9 - $484.47 $938,415 - $2.05 Million	-4,229 Reduced 45.91%	4,982 $1.92 Million
Q2 2021 Aug 03, 2021	BUY	$129.91 - $234.98 $1.2 Million - $2.16 Million	9,211 New	9,211 $2.16 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Cookson Peirce & CO Inc with notifications on news.